• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受透析的慢性肾脏病患者体内的二甲基精氨酸与炎症标志物

Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis.

作者信息

Oner-Iyidogan Yildiz, Oner Pernur, Kocak Hikmet, Gurdol Figen, Bekpinar Seldag, Unlucerci Yesim, Caliskan Yasar, Cetinalp-Demircan Pinar, Kocak Taner, Turkmen Aydin

机构信息

Medical Laboratory Programme, Medical Services Training School, Istanbul University, Cerrahpasa, Istanbul, Turkey.

出版信息

Clin Exp Med. 2009 Sep;9(3):235-41. doi: 10.1007/s10238-009-0035-3. Epub 2009 Feb 24.

DOI:10.1007/s10238-009-0035-3
PMID:19238516
Abstract

The aim of this study was to investigate the pro-oxidant and proinflammatory biomarkers and their relationship with dimethylarginines (DMAs) in patients at various stages of chronic kidney disease (CKD). We studied 114 CKD patients, 36 were hemodialyzed, 41 peritoneal dialyzed and 37 nondialyzed (early stage) CKD patients. The control group consisted of 31 healthy subjects. Plasma levels of asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), L-arginine, nitric oxide (NO) and proinflammatory cytokines (TNF-alpha and IL-6) were determined, and their relationships with the degree of disease were evaluated. Both DMAs were at high levels in all CKD patients, whereas arginine concentrations were low in patients undergoing dialysis. Elevated TNF-alpha and IL-6 in CKD patients were indicative of ongoing chronic inflammatory state. A significant positive correlation between SDMA and creatinine suggests that plasma SDMA level may be an index for renal function.

摘要

本研究旨在调查慢性肾脏病(CKD)各阶段患者的促氧化剂和促炎生物标志物及其与二甲基精氨酸(DMAs)的关系。我们研究了114例CKD患者,其中36例接受血液透析,41例接受腹膜透析,37例未透析(早期)CKD患者。对照组由31名健康受试者组成。测定了血浆不对称二甲基精氨酸(ADMA)、对称二甲基精氨酸(SDMA)、L-精氨酸、一氧化氮(NO)和促炎细胞因子(TNF-α和IL-6)的水平,并评估了它们与疾病程度的关系。所有CKD患者的两种DMAs水平均较高,而接受透析的患者精氨酸浓度较低。CKD患者中TNF-α和IL-6升高表明存在持续的慢性炎症状态。SDMA与肌酐之间存在显著正相关,提示血浆SDMA水平可能是肾功能的一个指标。

相似文献

1
Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis.接受透析的慢性肾脏病患者体内的二甲基精氨酸与炎症标志物
Clin Exp Med. 2009 Sep;9(3):235-41. doi: 10.1007/s10238-009-0035-3. Epub 2009 Feb 24.
2
Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease.对称二甲基精氨酸作为慢性肾脏病中的促炎剂。
Clin J Am Soc Nephrol. 2011 Oct;6(10):2374-83. doi: 10.2215/CJN.01720211. Epub 2011 Aug 4.
3
Accumulation of symmetric dimethylarginine in hepatorenal syndrome.对称二甲基精氨酸在肝肾综合征中的蓄积。
Exp Biol Med (Maywood). 2006 Jan;231(1):70-5. doi: 10.1177/153537020623100108.
4
Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.对称二甲基精氨酸(SDMA)在预测非透析慢性肾脏病的肾脏和心血管结局方面优于不对称二甲基精氨酸(ADMA)和其他甲基精氨酸。
Clin Res Cardiol. 2018 Mar;107(3):201-213. doi: 10.1007/s00392-017-1172-4. Epub 2017 Nov 3.
5
Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.非 ST 段抬高型心肌梗死患者中循环中二甲基精氨酸水平与慢性肾脏病及长期临床转归的关系。
PLoS One. 2012;7(11):e48499. doi: 10.1371/journal.pone.0048499. Epub 2012 Nov 19.
6
Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.肾衰竭患者血清中不对称(ADMA)和对称(SDMA)二甲基精氨酸的浓度。
Kidney Int Suppl. 2001 Feb;78:S14-8. doi: 10.1046/j.1523-1755.2001.59780014.x.
7
Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases.慢性肾脏病患者血清不对称(ADMA)和对称(SDMA)二甲基精氨酸的浓度
Clin Chim Acta. 2003 Oct;336(1-2):1-12. doi: 10.1016/s0009-8981(03)00338-3.
8
Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.严重脓毒症患者内源性一氧化氮抑制剂的时间进程。
Minerva Anestesiol. 2010 May;76(5):325-33.
9
Unchanged plasma levels of dimethylarginines and nitric oxide in chronic hepatitis C.慢性丙型肝炎患者血浆中不对称二甲基精氨酸和一氧化氮水平无变化。
Scand J Gastroenterol. 2009;44(2):224-8. doi: 10.1080/00365520802400917.
10
HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application.高效液相色谱法测定血浆中二甲精氨酸:方法验证及初步临床应用。
Clin Chim Acta. 2010 Nov 11;411(21-22):1632-6. doi: 10.1016/j.cca.2010.06.001. Epub 2010 Jun 11.

引用本文的文献

1
Plausible diagnostic value of urinary isomeric dimethylarginine ratio for diabetic nephropathy.尿同型二甲基精氨酸比值对糖尿病肾病的诊断价值。
Sci Rep. 2020 Feb 19;10(1):2970. doi: 10.1038/s41598-020-59897-1.
2
Symmetric dimethylarginine concentrations in dogs with International Renal Interest Society stage 4 chronic kidney disease undergoing intermittent hemodialysis.国际肾脏学会 4 期慢性肾脏病行间歇性血液透析犬对称二甲基精氨酸浓度。
J Vet Intern Med. 2019 Nov;33(6):2635-2643. doi: 10.1111/jvim.15612. Epub 2019 Sep 12.
3
Asymmetric dimethyarginine as marker and mediator in ischemic stroke.

本文引用的文献

1
Protein damage and inflammation in uraemia and dialysis patients.尿毒症和透析患者的蛋白质损伤与炎症
Nephrol Dial Transplant. 2007 Jul;22 Suppl 5:v20-36. doi: 10.1093/ndt/gfm294.
2
Adipokines and gut hormones in end-stage renal disease.终末期肾病中的脂肪因子与肠道激素
Perit Dial Int. 2007 Jun;27 Suppl 2:S298-302.
3
Nitric oxide, malnutrition and chronic renal failure.一氧化氮、营养不良与慢性肾衰竭
不对称二甲基精氨酸作为缺血性卒中的标志物和介质
Int J Mol Sci. 2012 Nov 28;13(12):15983-6004. doi: 10.3390/ijms131215983.
4
Asymmetric dimethylarginine, endothelial dysfunction and renal disease.不对称二甲基精氨酸、内皮功能障碍与肾脏疾病
Int J Mol Sci. 2012;13(9):11288-11311. doi: 10.3390/ijms130911288. Epub 2012 Sep 10.
5
Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease.对称二甲基精氨酸作为慢性肾脏病中的促炎剂。
Clin J Am Soc Nephrol. 2011 Oct;6(10):2374-83. doi: 10.2215/CJN.01720211. Epub 2011 Aug 4.
6
The role of asymmetric and symmetric dimethylarginines in renal disease.不对称和对称二甲基精氨酸在肾脏疾病中的作用。
Nat Rev Nephrol. 2011 May;7(5):275-85. doi: 10.1038/nrneph.2011.31. Epub 2011 Mar 29.
Cardiovasc Hematol Agents Med Chem. 2007 Apr;5(2):155-61. doi: 10.2174/187152507780363214.
4
Inflammatory syndrome in patients on hemodialysis.血液透析患者的炎症综合征
J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S274-80. doi: 10.1681/ASN.2006080926.
5
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis.对称二甲基精氨酸(SDMA)作为肾功能的内源性标志物——一项荟萃分析。
Nephrol Dial Transplant. 2006 Sep;21(9):2446-51. doi: 10.1093/ndt/gfl292. Epub 2006 Jun 9.
6
Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function.胱硫醚β-合酶缺乏所致同型胱氨酸尿症中的不对称二甲基精氨酸:肾功能的相关性
J Inherit Metab Dis. 2006 Feb;29(1):30-7. doi: 10.1007/s10545-006-0208-0.
7
Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC.采用高效液相色谱法测定生物样品中内源性一氧化氮合酶抑制剂不对称二甲基精氨酸
Methods Mol Med. 2005;108:263-74. doi: 10.1385/1-59259-850-1:263.
8
Dyslipidemias in patients who have chronic kidney disease.患有慢性肾病患者的血脂异常
Med Clin North Am. 2005 May;89(3):689-99. doi: 10.1016/j.mcna.2004.11.002.
9
Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress.维持性血液透析起始对炎症和氧化应激生物标志物的影响。
Kidney Int. 2004 Jun;65(6):2371-9. doi: 10.1111/j.1523-1755.2004.00656.x.
10
[Metabolic consequences of inflammation in kidney failure].[肾衰竭中炎症的代谢后果]
Nephrologie. 2003;24(7):383-6.